Soleno Therapeutics Inc (SLNO.OQ)
23 Feb 2018
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|49||2017||President, Chief Executive Officer, Interim Principal Financial and Accounting Officer, Director|
|67||2017||Interim Chief Financial Officer|
|55||2013||Vice President - Research and Development|
|78||2014||Chairman of the Board|
- BRIEF-Soleno Therapeutics Announces Successful End-Of-Phase II Meeting With FDA For DCCR In Prader-Willi Syndrome
- BRIEF-Soleno Therapeutics Files For Resale Of Up To 14.2 Mln Shares
- BRIEF-Jack W. Schuler Living Trust Reports 13.4 Pct Stake In Soleno Therapeutics As Of December 15
- BRIEF-Soleno Therapeutics Says Board Resolved To Decrease Size Of Board From Ten To Seven
- BRIEF-Birchview Capital LP Reports A 6.17 Pct Passive Stake In Soleno Therapeutics